FAB24: Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial
Study Details
Study Description
Brief Summary
The goal of this multi-center, randomized, controlled trial is to evaluate the effectiveness of a 2 year versus 4 year bracing protocol in preventing isolated clubfoot recurrence within the first year post-treatment, and to evaluate factors associated with recurrence in isolated clubfoot.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study is based on the hypothesis that prolonged bracing will reduce clubfoot recurrence. In addition to bracing length, the study will determine if other factors in addition to duration of brace wear are associated with recurrence.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 4-Year Bracing Arm This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method. |
Device: Foot Abduction Brace (FAB)
After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in.
|
Other: 2-Year Bracing Arm This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method. |
Device: Foot Abduction Brace (FAB)
After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in.
|
Outcome Measures
Primary Outcome Measures
- Kaplan-Meier Recurrence-Free Survival Probability for Clubfoot Affected Limbs [From end of bracing treatment until the earliest recurrence up to 1 year (allowing for per-protocol visit window of 1.2 years) after the assigned treatment (2- or 4-year bracing) is discontinued.]
Kaplan-Meier recurrence-free survival probability for each limb affected by clubfoot up to 1 year after bracing is discontinued. For patients with bilateral clubfoot, each limb was assessed. Bilateral patients contribute data for both limbs and unilateral patients contribute data for the affected limb. Recurrence is defined as the development of any of the following deformities in isolation or in combination that require repeat cast application or surgical intervention: hindfoot varus, ankle equinus, midfoot adduction, midfoot cavus, or forefoot pronation. Clubfoot recurrence was determined by the local Principal Investigator.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subject < 1 year of age when treatment initiated at local site
-
Confirmed diagnosis of Isolated Clubfoot
-
At least one foot demonstrates fixation of the foot in equinus, forefoot adduction, cavus and hindfoot varus
-
Deformity was present at birth
Exclusion Criteria:
-
Previous foot abduction bracing
-
Previous surgical correction (excluding Tenotomy)
-
Dysmorphic features, additional anomalies (i.e. congenital heart disease, hypospadias, a genetic syndrome), or developmental delay
-
Neurologic cause for clubfoot (i.e. myelomeningocele or sacral agenesis)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shriners Hospital for Children | Sacramento | California | United States | 95817 |
2 | Nemours Children's Hospital | Orlando | Florida | United States | 32827 |
3 | Shriners Hospital for Children | Lexington | Kentucky | United States | 40502 |
4 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
5 | Shriners Hospital for Children | Saint Louis | Missouri | United States | 63131 |
6 | Shriners Hospital for Children | Portland | Oregon | United States | 97239 |
7 | Seattle Children's Hospital | Seattle | Washington | United States | 98105 |
Sponsors and Collaborators
- Washington University School of Medicine
- Shriners Hospitals for Children
Investigators
- Principal Investigator: Matthew B Dobbs, MD, Washington University School of Medicine
Study Documents (Full-Text)
More Information
Publications
None provided.- 201110158
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | 4-Year Bracing Arm | 2-Year Bracing Arm |
---|---|---|
Arm/Group Description | This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 4 years. | This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 2 years. |
Period Title: Overall Study | ||
STARTED | 70 | 69 |
Started Bracing | 69 | 67 |
Data for at Least One Follow-up After Brace Discontinuation Ascertained | 44 | 55 |
COMPLETED | 38 | 41 |
NOT COMPLETED | 32 | 28 |
Baseline Characteristics
Arm/Group Title | 4-Year Bracing Arm | 2-Year Bracing Arm | Total |
---|---|---|---|
Arm/Group Description | This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 4 years. | This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 2 years. | Total of all reporting groups |
Overall Participants | 70 | 69 | 139 |
Age (Count of Participants) | |||
<=18 years |
70
100%
|
69
100%
|
139
100%
|
Between 18 and 65 years |
0
0%
|
0
0%
|
0
0%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Age (Months) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [Months] |
1.8
(1.7)
|
1.8
(1.5)
|
1.8
(1.6)
|
Sex: Female, Male (Count of Participants) | |||
Female |
18
25.7%
|
23
33.3%
|
41
29.5%
|
Male |
52
74.3%
|
46
66.7%
|
98
70.5%
|
Race (NIH/OMB) (Count of Participants) | |||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
Asian |
4
5.7%
|
1
1.4%
|
5
3.6%
|
Native Hawaiian or Other Pacific Islander |
1
1.4%
|
0
0%
|
1
0.7%
|
Black or African American |
4
5.7%
|
4
5.8%
|
8
5.8%
|
White |
57
81.4%
|
59
85.5%
|
116
83.5%
|
More than one race |
3
4.3%
|
4
5.8%
|
7
5%
|
Unknown or Not Reported |
1
1.4%
|
1
1.4%
|
2
1.4%
|
Region of Enrollment (participants) [Number] | |||
United States |
70
100%
|
69
100%
|
139
100%
|
Measure Description: Laterality of isolated clubfoot at enrollment (Count of Participants) | |||
Unilateral |
35
50%
|
35
50.7%
|
70
50.4%
|
Bilateral |
35
50%
|
34
49.3%
|
69
49.6%
|
Family history of clubfoot in first-degree relative (Count of Participants) | |||
Presence |
9
12.9%
|
10
14.5%
|
19
13.7%
|
Absence |
61
87.1%
|
59
85.5%
|
120
86.3%
|
Outcome Measures
Title | Kaplan-Meier Recurrence-Free Survival Probability for Clubfoot Affected Limbs |
---|---|
Description | Kaplan-Meier recurrence-free survival probability for each limb affected by clubfoot up to 1 year after bracing is discontinued. For patients with bilateral clubfoot, each limb was assessed. Bilateral patients contribute data for both limbs and unilateral patients contribute data for the affected limb. Recurrence is defined as the development of any of the following deformities in isolation or in combination that require repeat cast application or surgical intervention: hindfoot varus, ankle equinus, midfoot adduction, midfoot cavus, or forefoot pronation. Clubfoot recurrence was determined by the local Principal Investigator. |
Time Frame | From end of bracing treatment until the earliest recurrence up to 1 year (allowing for per-protocol visit window of 1.2 years) after the assigned treatment (2- or 4-year bracing) is discontinued. |
Outcome Measure Data
Analysis Population Description |
---|
For patients with bilateral clubfoot, each limb was assessed. Bilateral patients contribute data for both limbs and unilateral patients contribute data for the affected limb. Analysis includes limbs from participants who started bracing and attended at least one visit within one year after discontinuing bracing. |
Arm/Group Title | 4-Year Bracing Arm | 2-Year Bracing Arm |
---|---|---|
Arm/Group Description | This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in. | This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for either 2 or 4 years depending on which arm they are in. |
Measure Participants | 44 | 55 |
Measure limb | 65 | 82 |
Number (95% Confidence Interval) [survival probability] |
0.81
|
0.65
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | 4-Year Bracing Arm, 2-Year Bracing Arm |
---|---|---|
Comments | ||
Type of Statistical Test | Other | |
Comments | P-value by chi-square comparing the Kaplan-Meier recurrence-free survival probability at 1.2 years post treatment with robust estimate of standard error due to the a priori assumption that data from bilateral limbs are correlated. | |
Statistical Test of Hypothesis | p-Value | 0.03 |
Comments | ||
Method | Chi-squared | |
Comments |
Adverse Events
Time Frame | Adverse events for each participant were evaluated from participant randomization to the last study visit attended. For participants that completed the study, the last study visit is 60 months after brace fitting. For participants that did not complete the study, the last study visit is the final study visit that the participant attended. | |||
---|---|---|---|---|
Adverse Event Reporting Description | An adverse event is any new untoward medical occurrence or worsening of a preexisting medical condition that occurs in association with study procedures (consent process, questionnaires, loss of protected health information) or treatment reaction in excess of expectation. Serious adverse events require extensive or urgent intervention/corrective action, pose immediate threat of harm, or death. Relatedness is defined as: clearly related, likely related, possibly related, or clearly not related. | |||
Arm/Group Title | 4-Year Bracing Arm | 2-Year Bracing Arm | ||
Arm/Group Description | This group has been randomized to 4 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 4 years. | This group has been randomized to 2 years of bracing after correction of clubfoot using the Ponseti Method. Foot Abduction Brace (FAB): After clubfoot correction, the participants will wear the FAB 23 hours/day for 3 months and then wean to naps and nighttime (8-12 hours/day) for 2 years. | ||
All Cause Mortality |
||||
4-Year Bracing Arm | 2-Year Bracing Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/70 (0%) | 0/69 (0%) | ||
Serious Adverse Events |
||||
4-Year Bracing Arm | 2-Year Bracing Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/70 (0%) | 0/69 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
4-Year Bracing Arm | 2-Year Bracing Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/70 (0%) | 0/69 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Matthew Dobbs MD |
---|---|
Organization | Washington University School of Medicine |
Phone | 561-844-5255 |
mdobbs@paleyinstitute.org |
- 201110158